|
1
|
Hung CH, Wang CN, Cheng HH, Liao JW, Chen
YT, Chao YW, Jiang JL and Lee CC: Baicalin ameliorates
imiquimod-induced psoriasis-like inflammation in mice. Planta Med.
84:1110–1117. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parisi R, Symmons DP, Griffiths CE and
Ashcroft DM; Identification and Management of Psoriasis and
AssociatedComorbidiTy(IMPACT) project team: Global epidemiology of
psoriasis: A systematic review of incidence and prevalence. J
Invest Dermatol. 133:377–385. 2013. View Article : Google Scholar
|
|
3
|
Queiro R, Tejón P, Alonso S and Coto P:
Age at disease onset: A key factor for understanding psoriatic
disease. Rheumatology (Oxford). 53:1178–1185. 2014. View Article : Google Scholar
|
|
4
|
Jankovic S, Raznatovic M, Marinkovic J,
Jankovic J and Maksimovic N: Risk factors for psoriasis: A
case-control study. J Dermatol. 36:328–334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huerta C, Rivero E and Rodriguez LA:
Incidence and risk factors for psoriasis in the general population.
Arch Dermatol. 143:1559–1565. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Armstrong AW, Harskamp CT, Dhillon JS and
Armstrong EJ: Psoriasis and smoking: A systematic review and
meta-analysis. Br J Dermatol. 170:304–314. 2014. View Article : Google Scholar
|
|
7
|
Brenaut E, Horreau C, Pouplard C,
Barnetche T, Paul C, Richard MA, Joly P, Le Maitre M, Aractingi S,
Aubin F, et al: Alcohol consumption and psoriasis: A systematic
literature review. J Eur Acad Dermatol Venereol. 27(Suppl 3):
S30–S35. 2013. View Article : Google Scholar
|
|
8
|
Frankel HC, Han J, Li T and Qureshi AA:
The association between physical activity and the risk of incident
psoriasis. Arch Dermatol. 148:918–924. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Griffiths CEM, van der Walt JM, Ashcroft
DM, Flohr C, Naldi L, Nijsten T and Augustin M: The global state of
psoriasis disease epidemiology: A workshop report. Br J Dermatol.
177:e4–e7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lowes MA, Suárez-Fariñas M and Krueger JG:
Immunology of psoriasis. Annu Rev Immunol. 32:227–255. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chiricozzi A, Romanelli P, Volpe E,
Borsellino G and Romanelli M: Scanning the immunopathogenesis of
psoriasis. Int J Mol Sci. 19:1792018. View Article : Google Scholar :
|
|
12
|
Lovato P, Norsgaard H, Tokura Y and Røpke
MA: Calcipotriol and betamethasone dipropionate exert additive
inhibitory effects on the cytokine expression of inflammatory
dendritic cell-Th17 cell axis in psoriasis. J Dermatol Sci.
81:153–164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jadali Z and Eslami MB: T cell immune
responses in psoriasis. Iran J Allergy Asthma Immunol. 13:220–230.
2014.PubMed/NCBI
|
|
14
|
Boonstra A, Barrat FJ, Crain C, Heath VL,
Savelkoul HF and O'Garra A: 1alpha,25-dihydroxyvitamin d3 has a
direct effect on naive CD4(+) T cells to enhance the development of
Th2 cells. J Immunol. 167:4974–4980. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Owczarczyk-Saczonek A, Czerwińska J and
Placek W: The role of regulatory T cells and anti-inflammatory
cytokines in psoriasis. Acta Dermatovenerol Alp Pannonica Adriat.
27:17–23. 2018.PubMed/NCBI
|
|
16
|
Turkson J: STAT proteins as novel targets
for cancer drug discovery. Expert Opin Ther Targets. 8:409–422.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang Y, Pan HF and Ye DQ: Therapeutic
potential of STAT4 in autoimmunity. Expert Opin Ther Targets.
18:945–960. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mangelsdorf DJ, Thummel C, Beato M,
Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M,
Chambon P and Evans RM: The nuclear receptor superfamily: The
second decade. Cell. 83:835–839. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee HH, Mun MJ, Kim TH, Kim YS, Jang WC
and Hwang JY: Relationships between vitamin D receptor genetic
polymorphisms and endometriosis in Korean women. Clin Exp Obstet
Gynecol. 46:876–880. 2019.
|
|
20
|
O'Kelly J, Hisatake J, Hisatake Y, Bishop
J, Norman A and Koeffler HP: Normal myelopoiesis but abnormal T
lymphocyte responses in vitamin D receptor knockout mice. J Clin
Invest. 109:1091–1099. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gopinath SD: Inhibition of Stat3 signaling
ameliorates atrophy of the soleus muscles in mice lacking the
vitamin D receptor. Skelet Muscle. 7:22017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lei XJ, Xu YL, Yang YQ, Bing YW and Zhao
YX: Vitamin D receptor regulates high-level glucose induced retinal
ganglion cell damage through STAT3 pathway. Eur Rev Med Pharmacol
Sci. 22:7509–7516. 2018.PubMed/NCBI
|
|
23
|
Rizvi S, Chaudhari K and Syed BA: The
psoriasis drugs market. Nat Rev Drug Discov. 14:745–746. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng S, Lin Z, Wang Y, Wang Z, Li P and
Zheng Y: Psoriasis therapy by Chinese medicine and modern agents.
Chin Med. 13:162018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu M, Deng Y, Li S, Chen Y, Guo D, Jin X,
Xu Q, Li B and Li F: The immunoregulatory effects of traditional
Chinese medicine on psoriasis via its action on interleukin:
Advances and considerations. Am J Chin Med. 46:739–750. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xue M, Jiang ZZ, Liu JP, Zhang LY, Wang T,
Wang H, Liu L and Zhou ZX: Comparative study on the
anti-inflammatory and immune suppressive effect of Wilforlide A.
Fitoterapia. 81:1109–1112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Q: Triptolide and its expanding
multiple pharmacological functions. Int Immunopharmacol.
11:377–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Menter A, Gottlieb A, Feldman SR, Van
Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA,
Korman NJ, et al: Guidelines of care for the management of
psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis
and guidelines of care for the treatment of psoriasis with
biologics. J Am Acad Dermatol. 58:826–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shan C, Yuan L, Xiuzhen B and Aiju Q:
Treatment of psoriasis vulgaris by oral administration of yin xie
ping granules - a clinical report of 60 cases. J Tradit Chin Med.
26:198–201. 2006.PubMed/NCBI
|
|
30
|
Chen M, Chen Z, Liu J, Tu S and Gao Y: The
effect of Chinese medicine 'Psoriasis 1' on TNF-α secretion of
psoriatic neutrophils in vitro. Lishizhen Med Mater Media Res.
29:565–567. 2018.In Chinese.
|
|
31
|
Sun W, Chen YJ, Deng WY, Huang SH, Li Y,
Liu J and Cha XS: Effects of Yinxieyihao on nuclear factor kappa B
for imiquimod induced psoriasis mice model. Chin J Derm Venereol.
94:79–81. 2017.
|
|
32
|
Gao Y, Sun W, Gao Y, Li Y, Liu J and Zha
X: Effects of Yinxieyihao on down-regulated inflammatory factors
and NF-κB in psoriasis model mices. Chin J Derm Venereol.
31:1131–1134. 2017.In Chinese.
|
|
33
|
Bouillon R, Carmeliet G, Verlinden L, van
Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C and Demay M:
Vitamin D and human health: Lessons from vitamin D receptor null
mice. Endocr Rev. 29:726–776. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hawkes JE, Chan TC and Krueger JG:
Psoriasis pathogenesis and the development of novel targeted immune
therapies. J Allergy Clin Immunol. 140:645–653. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim J, Lee J, Gonzalez J, Fuentes-Duculan
J, Garcet S and Krueger JG: Proportion of
CD4+CD49b+LAG-3+ type 1 regulatory
T cells in the blood of psoriasis patients inversely correlates
with psoriasis area and severity index. J Invest Dermatol.
138:2669–2672. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Diani M, Galasso M, Cozzi C, Sgambelluri
F, Altomare A, Cigni C, Frigerio E, Drago L, Volinia S, Granucci F,
et al: Blood to skin recirculation of CD4+ memory T
cells associates with cutaneous and systemic manifestations of
psoriatic disease. Clin Immunol. 180:84–94. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Di Cesare A, Di Meglio P and Nestle FO:
The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J
Invest Dermatol. 129:1339–1350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gooderham MJ, Papp KA and Lynde CW:
Shifting the focus-the primary role of IL-23 in psoriasis and other
inflammatory disorders. J Eur Acad Dermatol Venereol. 32:1111–1119.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ganti KP, Mukherji A, Surjit M, Li M and
Chambon P: Similarities and differences in the transcriptional
control of expression of the mouse TSLP gene in skin epidermis and
intes-tinal epithelium. Proc Natl Acad Sci USA. 114:E951–E960.
2017. View Article : Google Scholar
|
|
40
|
Sun W, Gao Y, Yu X, Yuan Y, Yi J, Zhang Z,
Cheng Y, Li Y, Peng X and Cha X: 'Psoriasis 1' reduces
psoriasis-like skin inflammation by inhibiting the VDR-mediated
nuclear NF-κB and STAT signaling pathways. Mol Med Rep.
18:2733–2743. 2018.PubMed/NCBI
|
|
41
|
Reinhardt TA and Horst RL: Phorbol
12-myristate 13-acetate and 1,25-dihydroxyvitamin D3 regulate
1,25-dihydroxyvitamin D3 receptors synergistically in rat
osteosarcoma cells. Mol Cell Endocrinol. 101:159–165. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gocek E, Kielbinski M and Marcinkowska E:
Activation of intracellular signaling pathways is necessary for an
increase in VDR expression and its nuclear translocation. FEBS
Lett. 581:1751–1757. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xue YL, Zhang SX, Zheng CF, Li YF, Zhang
LH, Hao YF, Wang S and Li XW: Silencing of STAT4 protects against
auto-immune myocarditis by regulating Th1/Th2 immune response via
inactivation of the NF-κB pathway in rats. Inflammation.
42:1179–1189. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Varikuti S, Oghumu S, Natarajan G, Kimble
J, Sperling RH, Moretti E, Kaplan MH and Satoskar AR: STAT4 is
required for the generation of Th1 and Th2, but not Th17 immune
responses during monophosphoryl lipid A adjuvant activity. Int
Immunol. 28:565–570. 2016. View Article : Google Scholar : PubMed/NCBI
|
